162 related articles for article (PubMed ID: 28734906)
1. Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes.
Shephard M; Shephard A; McAteer B; Regnier T; Barancek K
Clin Biochem; 2017 Dec; 50(18):1159-1163. PubMed ID: 28734906
[TBL] [Abstract][Full Text] [Related]
2. The analytical quality of point-of-care testing in the 'QAAMS' model for diabetes management in Australian aboriginal medical services.
Shephard MD; Gill JP
Clin Biochem Rev; 2006 Nov; 27(4):185-90. PubMed ID: 17581642
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care.
Spaeth BA; Shephard MD; Schatz S
Rural Remote Health; 2014; 14(4):2849. PubMed ID: 25359698
[TBL] [Abstract][Full Text] [Related]
4. An innovative Australian point-of-care model for urine albumin: creatinine ratio testing that supports diabetes management in indigenous medical services and has international application.
Shephard MD; Gill JP
Ann Clin Biochem; 2005 May; 42(Pt 3):208-15. PubMed ID: 15949156
[TBL] [Abstract][Full Text] [Related]
5. Review of the cultural safety of a national Indigenous point-of-care testing program for diabetes management.
Shephard M; O'Brien C; Burgoyne A; Croft J; Garlett T; Barancek K; Halls H; McAteer B; Motta L; Shephard A
Aust J Prim Health; 2016; 22(4):368-374. PubMed ID: 26330366
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices.
Sølvik UØ; Røraas T; Christensen NG; Sandberg S
Clin Chem; 2013 Dec; 59(12):1790-801. PubMed ID: 23958846
[TBL] [Abstract][Full Text] [Related]
7. Results of an innovative education, training and quality assurance program for point-of-care HbA1c testing using the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health Services.
Shephard MD; Gill JP
Clin Biochem Rev; 2003 Nov; 24(4):123-30. PubMed ID: 18568052
[TBL] [Abstract][Full Text] [Related]
8. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
[TBL] [Abstract][Full Text] [Related]
9. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
[TBL] [Abstract][Full Text] [Related]
10. Application of biological variation and sigma metrics to evaluate the performance of HbA
Kang F; Li W; Lou Y; Shan Z
Scand J Clin Lab Invest; 2022 Sep; 82(5):398-403. PubMed ID: 35872643
[TBL] [Abstract][Full Text] [Related]
11. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes.
Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S
Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656
[TBL] [Abstract][Full Text] [Related]
12. Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease.
Rowley KG; Daniel M; O'Dea K
Diabet Med; 2005 Jul; 22(7):833-9. PubMed ID: 15975095
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.
Saxton AT; Miranda JJ; Ortiz EJ; Pan W
Ann Glob Health; 2018 Nov; 84(4):618-624. PubMed ID: 30779508
[TBL] [Abstract][Full Text] [Related]
14. Results From 16 Years of Quality Surveillance of Urine Albumin to Creatinine Ratio Testing for a National Indigenous Point-of-Care Testing Program.
Regnier T; Shephard M; Shephard A; Graham P; DeLeon R; Shepherd S
Arch Pathol Lab Med; 2020 Oct; 144(10):1199-1203. PubMed ID: 33002152
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional comparison of point-of-care with laboratory HbA₁c in detecting diabetes in real-world remote Aboriginal settings.
Marley JV; Oh MS; Hadgraft N; Singleton S; Isaacs K; Atkinson D
BMJ Open; 2015 Mar; 5(3):e006277. PubMed ID: 25765020
[TBL] [Abstract][Full Text] [Related]
16. The National QAAMS Program - A Practical Example of PoCT Working in the Community.
Shephard MD; Gill JP
Clin Biochem Rev; 2010 Aug; 31(3):105-9. PubMed ID: 24150514
[TBL] [Abstract][Full Text] [Related]
17. Cultural and clinical effectiveness of the 'QAAMS' point-of-care testing model for diabetes management in Australian aboriginal medical services.
Shephard MD
Clin Biochem Rev; 2006 Aug; 27(3):161-70. PubMed ID: 17268584
[TBL] [Abstract][Full Text] [Related]
18. HbA
Kenealy T; Herd G; Musaad S; Wells S
Prim Care Diabetes; 2019 Apr; 13(2):170-175. PubMed ID: 30545795
[TBL] [Abstract][Full Text] [Related]
19. Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
Quigley M; Earnest A; Szwarcbard N; Wischer N; Andrikopoulos S; Green S; Zoungas S
PLoS One; 2022; 17(2):e0263511. PubMed ID: 35120182
[TBL] [Abstract][Full Text] [Related]
20. Fingerstick Precision and Total Error of a Point-of-Care HbA1c Test.
Arnold WD; Kupfer K; Hvidsten Swensen M; Fortner KS; Bays HE; Davis M; Klaff LJ; San George RC
J Diabetes Sci Technol; 2020 Sep; 14(5):890-895. PubMed ID: 30841743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
